HF
ZYME icon

HRT Financial’s Zymeworks ZYME Stock Holding History

HRT Financial’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-237,889
Closed -$5.96M – 5532
2026
Q1 		$5.96M Buy
237,889
+116,825
+96% +$2.76M 0.01% 897
2025
Q4 		$3.19M Buy
121,064
+52,603
+77% +$1.15M 0.01% 1010
2025
Q3 		$1.17M Buy
68,461
+35,703
+109% +$511K ﹤0.01% 1441
2025
Q2 		$411K Sell
32,758
-32,622
-50% -$389K ﹤0.01% 1698
2025
Q1 		$778K Sell
65,380
-30,594
-32% -$417K ﹤0.01% 1245
2024
Q4 		$1.41M Buy
95,974
+47,166
+97% +$660K 0.01% 901
2024
Q3 		$612K Buy
+48,808
New +$531K ﹤0.01% 1494
2023
Q2 		– Sell
-327,026
Closed -$2.96M – 3416
2023
Q1 		$2.96M Buy
+327,026
New +$2.85M 0.04% 433
2022
Q3 		– Sell
-133,794
Closed -$709K – 3619
2022
Q2 		$709K Buy
+133,794
New +$809K 0.01% 1246

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

HRT Financial's ZYME Position: Q2 2026 in Review

HRT Financial sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 237,889 shares — an estimated $5.96M sold.

HRT Financial first reported a position in ZYME in Q2 2022 and held it in 9 quarters. The position peaked at $5.96M in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • HRT Financial reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 237,889 Zymeworks shares in Q2 2026, an estimated $5.96M.
  • HRT Financial first reported a position in Zymeworks in Q2 2022 and held it in 9 quarters.
  • HRT Financial's Zymeworks position peaked at $5.96M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.